| Protocol to collect late latency auditory evoked potentials. | |
| | |
MedLine Citation:
|
PMID: 20209291 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
AIM: to compare the two methods used to control the artifacts created by eye movements during LLAEP capture using two recording channels. MATERIALS AND METHODS: this is a prospective study with the application of two LLAEP capturing methods (eye artifact subtraction and rejection limit control) in 10 normal hearing individuals. RESULTS: we did not observe statistically significant differences concerning the latency values obtained with the use of both methods, only concerning amplitude values. CONCLUSION: both methods were efficient to capture the LLAEP and to control the eye movement artifact. The rejection limit control method produced greater amplitude values. |
| | |
Authors:
|
Luzia Maria Pozzobom Ventura; Kátia de Freitas Alvarenga; Orozimbo Alves Costa Filho |
Publication Detail:
|
Type: Comparative Study; Journal Article |
Journal Detail:
|
Title: Brazilian journal of otorhinolaryngology Volume: 75 ISSN: 1808-8686 ISO Abbreviation: Braz J Otorhinolaryngol Publication Date: 2009 Nov-Dec |
Date Detail:
|
Created Date: 2010-03-08 Completed Date: 2010-06-22 Revised Date: 2011-10-04 |
Medline Journal Info:
|
Nlm Unique ID: 101207337 Medline TA: Braz J Otorhinolaryngol Country: Brazil |
Other Details:
|
Languages: eng Pagination: 879-83 Citation Subset: IM |
Affiliation:
|
Audiology Research Center, Craniofacial Anomaly Rehabilitation Hospital, Sao Paulo University. |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Acoustic Stimulation
/
instrumentation,
methods* Adult Evoked Potentials, Auditory / physiology* Female Humans Male Prospective Studies Reaction Time / physiology* Young Adult |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Standardizing selection criteria in nasal medication studies.
Next Document: C1494T mitochondrial DNA mutation, hearing loss, and aminoglycosides antibiotics.